Effects of zoledronic acid on disseminated tumour cells in women with early breast cancer

Trial Profile

Effects of zoledronic acid on disseminated tumour cells in women with early breast cancer

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Mar 2012

At a glance

  • Drugs Antineoplastics; Zoledronic acid
  • Indications Bone metastases; Early breast cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Mar 2012 Results published in Annals of Oncology.
    • 05 Nov 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top